Profile
TAK ZTS HLN TEVA VTRS NBIX
Company Name Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc. Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $42.13B $79.26B $43.23B $18.71B $15.67B $12.48B
Employees 49.28K 14.10K 25.41K 37.00K 32.00K 1.70K
CEO Mr. Christophe Weber Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Richard D. Francis Mr. Scott Andrew Smith Ph.D. Mr. Kyle W. Gano Ph.D.
Ratings
TAK ZTS HLN TEVA VTRS NBIX
Quant Rating Score 3 3 3 1 3 4
Quant Rating Neutral Neutral Neutral Strong Sell Neutral Buy
Trading
TAK ZTS HLN TEVA VTRS NBIX
Last Close $13.29 $175.67 $9.48 $17.03 $13.13 $123.29
High 52 $15.08 $199.94 $10.69 $18.96 $13.53 $153.15
Low 52 $12.6 $145.54 $8.01 $10.44 $10.05 $111.62
Price vs. 52 Week High -11.87 % -12.14 % -11.32 % -10.18 % -2.96 % -19.5 %
Price vs. 52 Week Low 5.48 % 20.7 % 18.35 % 63.12 % 30.65 % 10.46 %
Total Return
TAK ZTS HLN TEVA VTRS NBIX
1 Month Return -6.08 % -7.27 % -5.01 % -6.33 % 13.48 % 5.76 %
3 Month Return -11.04 % -3.95 % -3.95 % -6.07 % 12.03 % -18.29 %
6 Month Return 0.68 % 1.67 % 11.27 % 2.65 % 19.8 % -12.28 %
9 Month Return -9.84 % -6.75 % 13.81 % 31 % -0.98 % -5.63 %
YTD Return -6.87 % -10.99 % 15.19 % 63.12 % 21.24 % -6.43 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TAK ZTS HLN TEVA VTRS NBIX
Dividend Yield Percentage (TTM) 4.77 % 0.98 % 2.08 % - 3.66 % -
Dividend Paid and Capex Coverage Ration (TTM) 1.29 % 2.1 % - 5.06 % 2.39 % 13.12 %
Dividend Per Share (TTM) 0.63 % 1.73 % 0.16 % - 0.48 % -
Payout Ratio (TTM) 101.62 % 31.44 % - - -65.15 % -
Growth
TAK ZTS HLN TEVA VTRS NBIX
Asset Growth 8.25 % -4.28 % -2.18 % -1.2 % -4.67 % 37.27 %
Gross Profit Growth -16.6 % 3.7 % 5.85 % 9.64 % -0.9 % 26.06 %
Revenue Growth 5.87 % 5.74 % 4.09 % 6.16 % -5.14 % 26.76 %
Revenue 3 Year 33.13 % 31.98 % 13.9 % -6.92 % -35.32 % 71.93 %
Revenue 5 Year 149.89 % 53.64 % 32.87 % -23.33 % -41.73 % 308.36 %
Revenue 10 Year 154.38 % 103.1 % 32.87 % -40.82 % -26.57 % 44100.16 %
EBIT Growth 7.34 % 6.27 % 37.26 % -84.52 % -52.55 % 0.76 %
Net Income Growth -54.56 % 10.88 % -1.04 % 76.24 % -97.37 % 61.62 %
Net Income 3 Yeari Growth Per Share -61.74 % 47.55 % -8.67 % 86.29 % 104.09 % -41.58 %
Net Income 5 Yeari Growth Per Share 62.27 % 71.94 % 59.66 % 76.28 % -93.3 % 1054.95 %
Net Income 10 Yeari Growth Per Share 36.33 % 404.24 % 59.66 % -133.42 % -97.12 % 470.4 %
Operating Income Growth 7.34 % 6.27 % 37.26 % -84.52 % -52.55 % 0.76 %
Operating Cash Flow Growth (CFG) -34.47 % 23.06 % -16.48 % -13.96 % -5.18 % 14.88 %
Operating 3 Year CFG -36.76 % 14.12 % 22.08 % 10.09 % 13.84 % 62.6 %
Operating 5 Year CFG 139.61 % 37.69 % 118.54 % -48.98 % -48.37 % 275.6 %
Operating 10 Year CFG 335.67 % 274.61 % 118.54 % -67.94 % -16.8 % 1000.37 %
EPS Growth -54.92 % 12.64 % - 76.42 % -97.08 % 59.01 %
EPS Diluted Growth -54.86 % 12.92 % - 76.42 % -97.08 % 58.33 %
Book Value Per Share 13.54 % 15.25 % 1.35 % -7.25 % -1.92 % 28.15 %
Share Holder 3 Year Equity Growth Per Share 40.38 % 36.7 % -36.6 % -26.74 % -55.34 % 88.86 %
Share Holder 5 Year Equity Growth Per Share 73.27 % 139.55 % -39.41 % -53.44 % -27.35 % 353.33 %
Share Holder 10 Year Equity Growth Per Share 197.1 % 476.36 % -39.41 % -74.76 % 128.81 % 1167.34 %
Dividend Per Share Growth 1.95 % 15.15 % -85.58 % - -0.06 % -
Dividend 3 Year Growth Per Share 1.19 % 87.76 % -83.69 % - - -
Dividend 5 Year Growth Per Share 146.94 % 198.29 % -66.42 % -100 % - -
Dividend 10 Year Growth Per Share 103.93 % 665.58 % -66.42 % -100 % - -
Debt Growth 24.67 % -15.91 % -9.43 % -6.53 % -5.93 % 62.95 %
Free Cash Flow Growth -53.54 % 22.25 % -20.06 % -19.19 % -7.35 % 11.99 %
Updated On 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
TAK ZTS HLN TEVA VTRS NBIX
Gross Profit Margin TTM 62.47 % 68.87 % 59.91 % 49.87 % 40.26 % 98 %
Return on Assets TTM 1.99 % 16.93 % 3.26 % -2.38 % -1.97 % 10.92 %
Return on Equity TTM 4.04 % 47.99 % 6.54 % -14.58 % -4.43 % 15.68 %
Return on Capital Employed TTM 5.27 % 26.64 % 7.25 % 7.66 % -0.71 % 18.91 %
Net Income Per EBT TTM 109.03 % 79.65 % 65.38 % 175.89 % 92.81 % 73.98 %
EBT Per Ebit TTM 41.38 % 90.51 % 82.66 % -26.34 % 359.67 % 88.81 %
EBIT Per Revenue TTM 14.14 % 36.83 % 17.88 % 12.76 % -1.76 % 26.19 %
Cash Flow To Debt Ratio TTM 17.01 % 44.8 % - 13 % 13.05 % -
Receivables Turnover TTM 6.3 6.49 5.27 4.85 3.81 4.66
Payables Turnover TTM 4.13 7.05 1.25 3.55 7.23 0.47
Inventory Turnover TTM 1.41 1.18 3.09 2.13 2.2 0.98
Fixed Asset Turnover TTM 240.84 % 259.93 % 604.62 % 278.05 % 561.67 % 664.93 %
Asset Turnover TTM 31.2 % 63.75 % 33.71 % 40.19 % 33.6 % 63.45 %
Operating Cash Flow Per Share TTM 545.34 6.5 - 2.18 1.93 4.71
Free Cash Flow Per Share TTM 309.43 5.1 - 1.75 1.6 4.35
Cash Per Share TTM 57513.46 % 378.45 % 5.72 % 292.94 % 157.41 % 1214.64 %
Operating Cash Flow Sales Ratio TTM 18.9 % 32.18 % - 14.71 % 15.29 % 21.24 %
Free Cash Flow Operating Cash Flow Ratio TTM 56.74 % 78.37 % - 80.23 % 83.19 % 92.38 %
Cash Flow Coverage Ratios TTM 17.01 % 44.8 % - 13 % 13.05 % -
Price To Free Cash Flows Ratio TTM 13.34 34.34 - 9.45 8.19 28.36
Price To Operating Cash Flows Ratio TTM 3.76 27.02 - 7.82 6.81 26.16
Price Cash Flow Ratio TTM 3.76 27.02 - 7.82 6.81 26.16
Income Statement (TTM)
TAK ZTS HLN TEVA VTRS NBIX
Revenue $4263.76B $8.54B $11.3B $15.85B $15.43B $1.89B
Gross Profit $2321.31B $5.83B $6.96B $7.65B $6.44B $1.85B
Gross Profit Ratio 54.44% 68.28% 61.6% 48.25% 41.74% 97.9%
EBITDA $900.33B $3.69B $2.35B $4.33B $3.52B $0.42B
Net Income $144.07B $2.34B $1.05B $-0.56B $0.05B $0.25B
EPS Diluted 91.16 5.07 0.11 -0.5 0.05 2.47
Balance Sheet (MRQ)
TAK ZTS HLN TEVA VTRS NBIX
Long Term Debt $5029.93B $6.75B $8.95B $18.48B $16.35B $0.26B
Total Liabilities $7834.79B $9.3B $17.33B $35.35B $27.22B $1.02B
Total Equity $7274.01B $4.99B $16.73B $8.13B $20.47B $2.23B
Total Investments $683.22B $0.02B $0.07B $0.01B $1.33B $1.63B
Total Debt $5463.39B $6.76B $9.46B $20.15B $18.37B $0.43B
Total Assets $15108.79B $14.29B $34.06B $43.48B $47.69B $3.25B
Cash Flow Statement (TTM)
TAK ZTS HLN TEVA VTRS NBIX
Net Income $144.07B $2.34B $1.05B $-0.62B $0.05B $0.25B
Inventory $-115.74B $-0.36B $-0.13B $0B $-0.61B $0.01B
Dividends Paid $-287.19B $-0.69B $-0.39B $0B $-0.58B $0B
Operating Cash Flow $640.32B $2.35B $1.72B $1.37B $2.8B $0.39B
Capital Expenditure $-480.73B $-0.73B $-0.34B $-0.53B $-0.47B $-0.03B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.32
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.33
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.33
ALVOW Alvotech 3.49
AMPH Amphastar Pharmaceuticals, Inc. 44.58
AMRX Amneal Pharmaceuticals, Inc. 8.33
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 56.315
AQST Aquestive Therapeutics, Inc. 4.585
ASRT Assertio Holdings, Inc. 0.9467
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 11.5
AYTU Aytu BioPharma, Inc. 1.471
ETFs With Exposure to TAK
Ticker ETF Name Weight Percentage Price
VEU Vanguard FTSE All-World ex-US Index Fund 0 59.045
FVD First Trust Value Line Dividend Index Fund 0.45 45.9151
CVY Invesco Zacks Multi-Asset Income ETF 0.646 26.7982
GCOW Pacer Global Cash Cows Dividend ETF 0.74 34.839
AFTY Pacer CSOP FTSE China A50 ETF 0.27 16.2826
AGGY WisdomTree Yield Enhanced U.S. Aggregate Bond Fund 0.04 43.3601
FPXI First Trust International Equity Opportunities ETF 2.11 49.0421
ICOW Pacer Developed Markets International Cash Cows 100 ETF 1.77 29.95
PPH VanEck Pharmaceutical ETF 0 87.9099
VETS Pacer Military Times Best Employers ETF 0.26 38.62
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.37 33.28
PTIN Pacer Trendpilot International ETF 0.26 28.902
VALT ETFMG Sit Ultra Short ETF 0.77 48.52
SLT Pacer Salt High truBeta US Market ETF 0.26 39.22
LSLT Pacer Salt Low truBeta US Market ETF 0.26 32
AVDE Avantis International Equity ETF 0.07 63.03
GERM ETFMG Treatments, Testing and Advancements ETF 0.89 19.1577
VIRS Pacer BioThreat Strategy ETF 0.26 40.025
FVL First Trust Value Line 100 Exchange-Traded Fund 0.45 23.1559
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 0.73 1.75
RTL The Necessity Retail REIT, Inc. 0.27 7.61
BAD B.A.D. ETF 1.51 11.91
AVSD Avantis Responsible International Equity ETF 0.08 57.06
DFIC Dimensional International Core Equity 2 ETF 0.0013496 26.355
VFWAX Vanguard FTSE All-World ex-US Index Fd Admiral 0 36.68
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0.00099769 25.405
TRPL Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF 0.26 41.14
Unlock